Rachel S Kerr (Rachel Kerr)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 2

Top Topics

Squamous Cell Carcinoma

Cross Sectional

Health Promotion

Top Venues

Journal of the National Cancer Institute

Health technology assessment (Winchester, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Zhaohui Jin, Jesse G Dixon, Jack M Fiskum, Hiral D Parekh, Frank A Sinicrope, Greg Yothers, Carmen J Allegra, Norman Wolmark, Daniel G Haller, Hans-Joachim Schmoll, Aimery de Gramont, Rachel S Kerr, Gilles Manceau, Eric Van Cutsem, Christopher Tweleves, Michael O'Connell, Leonard B Saltz, Sotaro Sadahiro, Charles David Blanke, Naohiro Tomita, Jean-Francois Seitz, Charles Erlichman, Takayuki Yoshino, Takeharu Yamanaka, Silvia Marsoni, Thierry André, Amit Mahipal, Richard M Goldberg, Thomas J George, Qian Shi
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database. Journal of the National Cancer Institute (2021)
Timothy J Iveson, Kathleen Anne Boyd, Rachel S Kerr, Jose Antonio Robles-Zurita, Mark P Saunders, Andrew H Briggs, Jim Cassidy, Niels Henrik Hollander, Josep Tabernero, Andrew Haydon, Bengt Glimelius, Andrea Harkin, Karen Allan, John McQueen, Sarah Pearson, Ashita Waterston, Louise Medley, Charles Wilson, Richard Ellis, Sharadah Essapen, Amandeep S Dhadda, Mark Harrison, Stephen Falk, Sherif Raouf, Charlotte Rees, Rene K Olesen, David J Propper, John A Bridgewater, Ashraf Azzabi, David Farrugia, Andrew Webb, David Cunningham, Tamas Hickish, Andrew Weaver, Simon Gollins, Harpreet S Wasan, James Paul
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT. Health technology assessment (Winchester, England) 23 (64) (2020)